Cestrian Capital Research.
  • Inner Circle
  • Ratings
  • Cestrian Circle
  • Quantitative
  • Cross Asset
  • Analyst Services
  • Team
Sign in Subscribe

META US Q2 - Capex Weighing Heavier - Do Nothing Pending A Proven Low

Last updated on  Jul 30, 2026
META US Q2 - Capex Weighing Heavier - Do Nothing Pending A Proven Low
Photo by Dima Solomin / Unsplash

This post is for subscribers only

Subscribe now

Already have an account? Sign in

Share this post:
Previous BE US - PT $350 - Accumulate $135-$180, STP <$135
Next QCOM US Q3 - Fundamentals Weak, Stock May Have Bottomed - Do Nothing
Cestrian Capital Research. © 2026
  • About Cestrian Capital Research, Inc
  • Ask Us Anything
  • Get SpotGamma
  • Get TrendSpider
  • SPX Options Structure
Powered by Ghost